13
Participants
Start Date
January 31, 2011
Primary Completion Date
April 30, 2013
Study Completion Date
April 30, 2013
Treprostinil
"Remodulin is supplied in concentrations of 1, 2.5 , 5, and 10 mg/mL and can be administered as supplied or diluted for intravenous (IV) infusion prior to administration.~Remodulin is indicated for subcutaneous (SC) or IV use only as a continuous infusion. Remodulin is preferably infused subcutaneously, but can be administered by a central IV line if the SC route is not tolerated. The infusion rate is initiated at 1.25 ng/kg/min. If this initial dose cannot be tolerated because of systemic effects, the infusion rate should be reduced to 0.625 ng/kg/min."
Emory Univeristy, Atlanta
University of Texas, Southwestern Medical Center, Dallas
University of California, Los Angeles, Los Angeles
Brigham and Women's Hospital, Boston
Lead Sponsor
University of California, Los Angeles
OTHER
Brigham and Women's Hospital
OTHER
University of Texas
OTHER
Emory University
OTHER
United Therapeutics
INDUSTRY